BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for MIRAGEN THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-09 5:26 pm Purchase |
2020-10-28 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
BIOTECHNOLOGY VALUE FUND L P | 7,584,219 9.990% |
7,584,219 (New Position) |
Filing |